Baylor College granted Cell Medica exclusive, worldwide rights to EBV-CTLs to treat EBV-positive lymphoproliferative disease in patients undergoing hematopoietic stem cell transplantation

Baylor College of Medicine

U.S. / Academic

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Cell Medica Ltd.

U.K. / Private Biopharma

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced